Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cerilliant
Baxter
Deloitte
US Department of Justice
Chubb
Harvard Business School
Cantor Fitzgerald
Chinese Patent Office

Generated: May 25, 2018

DrugPatentWatch Database Preview

CHLOROTHIAZIDE W/ RESERPINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Chlorothiazide W/ Reserpine, and when can generic versions of Chlorothiazide W/ Reserpine launch?

Chlorothiazide W/ Reserpine is a drug marketed by Watson Labs and is included in two NDAs.

The generic ingredient in CHLOROTHIAZIDE W/ RESERPINE is chlorothiazide; reserpine. There are forty-two drug master file entries for this compound. Additional details are available on the chlorothiazide; reserpine profile page.
Summary for CHLOROTHIAZIDE W/ RESERPINE
Drug patent expirations by year for CHLOROTHIAZIDE W/ RESERPINE
Synonyms for CHLOROTHIAZIDE W/ RESERPINE
8055-35-4
C33H40N2O9.C7H6ClN3O4S2
CHLOROTHIAZIDE AND RESERPINE
Chlorothiazide mixture with Reserpine
CHLOROTHIAZIDE-RESERPINE
CHLOROTHIAZIDE; RESERPINE
DTXSID40230389
LS-178508
SCHEMBL4058999

US Patents and Regulatory Information for CHLOROTHIAZIDE W/ RESERPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs CHLOROTHIAZIDE W/ RESERPINE chlorothiazide; reserpine TABLET;ORAL 084853-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs CHLOROTHIAZIDE W/ RESERPINE chlorothiazide; reserpine TABLET;ORAL 088151-001 Jun 9, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Merck
Argus Health
Mallinckrodt
Deloitte
Baxter
Fish and Richardson
US Department of Justice
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.